{"id":"https://openalex.org/W2003283881","doi":"https://doi.org/10.1080/09546630500375965","title":"Treatment costs of three nail lacquers used in onychomycosis","display_name":"Treatment costs of three nail lacquers used in onychomycosis","publication_year":2005,"publication_date":"2005-01-01","ids":{"openalex":"https://openalex.org/W2003283881","doi":"https://doi.org/10.1080/09546630500375965","mag":"2003283881","pmid":"https://pubmed.ncbi.nlm.nih.gov/16428149"},"language":"en","primary_location":{"id":"doi:10.1080/09546630500375965","doi":"https://doi.org/10.1080/09546630500375965","is_oa":false,"landing_page_url":"https://doi.org/10.1080/09546630500375965","pdf_url":null,"source":{"id":"https://openalex.org/S21432770","display_name":"Journal of Dermatological Treatment","issn_l":"0954-6634","issn":["0954-6634","1471-1753"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Dermatological Treatment","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111570724","display_name":"J.-P. Marty","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102197404","display_name":"Universit\u00e9 Paris-Sud","ror":"https://ror.org/028rypz17","country_code":"FR","type":"education","lineage":["https://openalex.org/I102197404","https://openalex.org/I277688954"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean\u2010Paul L. Marty","raw_affiliation_strings":["Unit\u00e9 de Recherche en Dermopharmacologie et Cosm\u00e9tologie, Facult\u00e9 de Pharmacie, Universit\u00e9 Paris Sud, 92296 Ch\u00e2tenay Malabry, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit\u00e9 de Recherche en Dermopharmacologie et Cosm\u00e9tologie, Facult\u00e9 de Pharmacie, Universit\u00e9 Paris Sud, 92296 Ch\u00e2tenay Malabry, France","institution_ids":["https://openalex.org/I102197404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103404372","display_name":"Julien Lambert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102047","display_name":"Antwerp University Hospital","ror":"https://ror.org/01hwamj44","country_code":"BE","type":"funder","lineage":["https://openalex.org/I4210102047"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Julien Lambert","raw_affiliation_strings":["University Hospital Antwerp, B\u20102650 Edegem, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital Antwerp, B\u20102650 Edegem, Belgium","institution_ids":["https://openalex.org/I4210102047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053918734","display_name":"Andreas J\u00e4ckel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andreas J\u00e4ckel","raw_affiliation_strings":["Galderma Laboratorium GmbH, Medical & Regulatory Affairs Department, D\u00fcsseldorf, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Galderma Laboratorium GmbH, Medical & Regulatory Affairs Department, D\u00fcsseldorf, Germany","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039669008","display_name":"Lucie Adjadj","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120458","display_name":"Galderma (France)","ror":"https://ror.org/034kxvk28","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210120458","https://openalex.org/I4210163806"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Lucie Adjadj","raw_affiliation_strings":["Galderma International SA, F\u201092927 La D\u00e9fense Cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Galderma International SA, F\u201092927 La D\u00e9fense Cedex, France","institution_ids":["https://openalex.org/I4210120458"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5039669008"],"corresponding_institution_ids":["https://openalex.org/I4210120458"],"apc_list":null,"apc_paid":null,"fwci":1.9813,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.84511735,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"16","issue":"5-6","first_page":"299","last_page":"307"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11253","display_name":"Nail Diseases and Treatments","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11253","display_name":"Nail Diseases and Treatments","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/onychomycosis","display_name":"onychomycosis","score":1.0},{"id":"https://openalex.org/keywords/amorolfine","display_name":"amorolfine","score":0.9829999804496765},{"id":"https://openalex.org/keywords/ciclopirox","display_name":"ciclopirox","score":0.9959999918937683},{"id":"https://openalex.org/keywords/tioconazole","display_name":"tioconazole","score":0.9869999885559082},{"id":"https://openalex.org/keywords/treatment-costs","display_name":"treatment costs","score":0.75},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9919999837875366},{"id":"https://openalex.org/keywords/toenail-infection","display_name":"toenail infection","score":0.5870000123977661},{"id":"https://openalex.org/keywords/fingernail-infection","display_name":"fingernail infection","score":0.9639999866485596}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.838232159614563},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.6284688711166382},{"id":"https://openalex.org/C2777852167","wikidata":"https://www.wikidata.org/wiki/Q37077","display_name":"Nail (fastener)","level":2,"score":0.5581988096237183},{"id":"https://openalex.org/C2780958618","wikidata":"https://www.wikidata.org/wiki/Q945621","display_name":"Average cost","level":2,"score":0.4386543929576874},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.4278647303581238},{"id":"https://openalex.org/C2983335822","wikidata":"https://www.wikidata.org/wiki/Q942582","display_name":"Cost analysis","level":2,"score":0.42000359296798706},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3569149672985077},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.0},{"id":"https://openalex.org/C133425853","wikidata":"https://www.wikidata.org/wiki/Q60571","display_name":"Neoclassical economics","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C191897082","wikidata":"https://www.wikidata.org/wiki/Q11467","display_name":"Metallurgy","level":1,"score":0.0},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C200601418","wikidata":"https://www.wikidata.org/wiki/Q2193887","display_name":"Reliability engineering","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077768","descriptor_name":"Ciclopirox","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005060","descriptor_name":"Europe","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005533","descriptor_name":"Foot Dermatoses","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D005533","descriptor_name":"Foot Dermatoses","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D006229","descriptor_name":"Hand Dermatoses","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006229","descriptor_name":"Hand Dermatoses","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009025","descriptor_name":"Morpholines","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D009025","descriptor_name":"Morpholines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014009","descriptor_name":"Onychomycosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014009","descriptor_name":"Onychomycosis","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1080/09546630500375965","doi":"https://doi.org/10.1080/09546630500375965","is_oa":false,"landing_page_url":"https://doi.org/10.1080/09546630500375965","pdf_url":null,"source":{"id":"https://openalex.org/S21432770","display_name":"Journal of Dermatological Treatment","issn_l":"0954-6634","issn":["0954-6634","1471-1753"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Dermatological Treatment","raw_type":"journal-article"},{"id":"pmid:16428149","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16428149","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of dermatological treatment","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320314128","display_name":"Les Laboratories Pierre Fabre","ror":"https://ror.org/04hdhz511"},{"id":"https://openalex.org/F4320325987","display_name":"Galderma","ror":"https://ror.org/05fswdm20"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W188848846","https://openalex.org/W1965684159","https://openalex.org/W1965845377","https://openalex.org/W1974984302","https://openalex.org/W1977168223","https://openalex.org/W1981034405","https://openalex.org/W1990195226","https://openalex.org/W2017693503","https://openalex.org/W2021029583","https://openalex.org/W2023214486","https://openalex.org/W2028574042","https://openalex.org/W2044615666","https://openalex.org/W2070999689","https://openalex.org/W2073148029","https://openalex.org/W2127255965","https://openalex.org/W2148434028","https://openalex.org/W2163914269","https://openalex.org/W2432133003","https://openalex.org/W4241216789","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W4210564386","https://openalex.org/W4243458253","https://openalex.org/W2114591542","https://openalex.org/W2045251301","https://openalex.org/W1977168223","https://openalex.org/W1965684159","https://openalex.org/W2158251029","https://openalex.org/W2332379369","https://openalex.org/W2332053385","https://openalex.org/W2137645256"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"assess":[2],"the":[3,8,36,55,66,73,78,88,138,163,175,189],"daily":[4,91,112,141,178],"treatment":[5,68,82,92,113,142,179],"costs":[6],"and":[7,19,24,39,47,86,94,115,122,152,158,212,224,230],"average":[9,67,80,90,111,140,177],"cost-effectiveness":[10],"of":[11,44,59,75,109,144,181,217],"three":[12],"topical":[13],"onychomycosis":[14,216],"therapies":[15,126],"-":[16,29],"amorolfine":[17,145,169,202],"5%":[18,203],"ciclopirox":[20,121,182,210],"8%":[21,211],"nail":[22,27,48,204],"lacquers":[23],"tioconazole":[25,213],"28%":[26,214],"solution":[28],"when":[30,124,155],"used":[31,63,128,156,199],"as":[32,129,200],"indicated":[33,130],"in":[34,107,222,226],"France,":[35,135,227],"UK,":[37,228],"Germany":[38,229],"Italy.":[40,231],"METHODS:":[41],"The":[42],"quantity":[43],"drug":[45],"required":[46],"size":[49],"measurements":[50],"were":[51,99,127],"investigated":[52],"and,":[53],"knowing":[54],"cost":[56,69,83,93,95,114,116,143,164,180,190],"per":[57,70,84,96,117,165,191],"bottle":[58],"each":[60],"study":[61],"drug,":[62],"to":[64,131,148,185],"calculate":[65],"patient.":[71],"Using":[72],"prevalence":[74],"infection":[76],"data,":[77],"weighted":[79,89,110,139,176],"total":[81],"patient":[85,97,118,166,192],"hence":[87],"cured,":[98],"calculated.":[100],"RESULTS:":[101],"Amorolfine":[102],"was":[103,146,170,183,194],"consistently":[104],"more":[105,207],"cost-effective":[106,208],"terms":[108],"cured":[119,167,193],"than":[120,209],"tioconazole,":[123],"all":[125],"treat":[132],"onychomycosis.":[133],"In":[134],"for":[136,168,215],"example,":[137],"found":[147,184],"be":[149,186],"euro":[150,153,171,187,195],"0.23":[151],"0.40":[154],"once":[157],"twice":[159],"a":[160],"week,":[161],"respectively;":[162],"84.":[172],"By":[173],"comparison,":[174],"0.81;":[188],"252.":[196],"CONCLUSIONS:":[197],"When":[198],"indicated,":[201],"lacquer":[205],"is":[206],"toenail,":[218],"fingernail":[219],"or":[220],"both":[221],"males":[223],"females":[225]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}